The latest closing stock price for Summit Therapeutics as of November 21, 2024 is 18.42.
An investor who bought $1,000 worth of Summit Therapeutics stock at the IPO in 2015 would have $808 today, roughly 1 times their original investment - a 6.10% compound annual growth rate over 10 years.
The all-time high Summit Therapeutics stock closing price was 31.93 on September 13, 2024.
The Summit Therapeutics 52-week high stock price is 33.89, which is 84% above the current share price.
The Summit Therapeutics 52-week low stock price is 1.89, which is 89.7% below the current share price.
The average Summit Therapeutics stock price for the last 52 weeks is 9.19.
An investor who bought $1,000 worth of Summit Therapeutics stock at the IPO in 2015 would have $808 today, roughly 1 times their original investment - a 6.10% compound annual growth rate over 10 years.
The all-time high Summit Therapeutics stock closing price was 31.93 on September 13, 2024.
The Summit Therapeutics 52-week high stock price is 33.89, which is 84% above the current share price.
The Summit Therapeutics 52-week low stock price is 1.89, which is 89.7% below the current share price.
The average Summit Therapeutics stock price for the last 52 weeks is 9.19.